Barely Significant
← all excerpts

Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase).

Biologics · 2008 · PMC2727789 · PMID 19707436

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
Rasburicase produced a highly significant (p < 0.001) decrease in UAL within 24 hrs after the first injection (group 1: 0.51 ± 0.39 mg/dL, group 2:1.83 ± 1.07 mg/dL) with a response rate of 100% and 93% respectively.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.